Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Vehicle-Controlled, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Three Once-Daily CLS001 Topical Gels Versus Vehicle Administered for 12 Weeks to Subjects With Papulopustular Rosacea
Conditions
Interventions
omiganan
placebo
Locations
17
United States
Radiant Research Inc.
Birmingham, Alabama, United States
ATS Clinical Research
Santa Monica, California, United States
The Savin Center, PC
New Haven, Connecticut, United States
Skin Care Research, Inc
Boca Raton, Florida, United States
Dunedin Research Specialists
Dunedin, Florida, United States
North Florida Dermatology Associates
Jacksonville, Florida, United States
Start Date
March 1, 2013
Primary Completion Date
March 1, 2014
Last Updated
May 20, 2015
NCT01872715
NCT01494467
NCT01933464
Lead Sponsor
Maruho Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions